Halobetasol Propionate 45802-0129
Product NDC
45802-0129- Manufacturer
- Padagis Israel Pharmaceuticals Ltd
- Dosage Form
- Cream
- Route
- Topical
- Product Type
- Human Prescription Drug
- Marketing Start
- August 4, 2008
- Listing Expires
- December 31, 2026
- Application
- ANDA077123
Need to source Halobetasol Propionate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Halobetasol Propionate | .5 mg/g |
Drug Class
Corticosteroid Hormone Receptor Agonists [MoA]Corticosteroid [EPC]
Packaging Options(2)
1 TUBE in 1 CARTON (45802-129-32) / 50 g in 1 TUBE
1 TUBE in 1 CARTON (45802-129-35) / 15 g in 1 TUBE